Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics

Journal of Experimental Medicine

Volumn 181, Issue 4, 1995, Pages 1365-1372

  Klein, Michél R ^a   van Baalen, Card A ^b   Holwerda, Agnes M ^a   Garde, Susana R Kerkhof ^a   Bende, Richard J ^a   Keet, Ireneus P M ^c   Eeftinck Schattenkerk, Jan Karel M ^d   Osterhaus, Albert D M E ^b   Schuitemaker, Hanneke ^a   Miedema, Frank ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c MUNICIPAL HEALTH SERVICE   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; PATHOGENESIS; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; CYTOTOXICITY, IMMUNOLOGIC; DISEASE PROGRESSION; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMAN; KINETICS; LONGITUDINAL STUDIES; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; VIREMIA;

EID: 0028950823     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.181.4.1365     Document Type: Article

References (42)

1. Pantaleo, G., C. Graziosi, and A.S. Fauci. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328: 327-335.
2. Miedema, F., L. Meyaard, M. Koot, M.R. Klein, M.T.L. Roos, M. Groenink, R.A.M. Fouchier, A.B. Van’t Wout, M. Tersmette, P.T.A. Schellekens, and H. Schuitemaker. 1994. Changing virus-host interactions in the course of HIV-1 infection. Immunol. Rev. 140: 35-72.
3. McMichael, A.J., F.M. Gotch, G.R. Noble, and P.A. Beare. 1983. Cytotoxic T-cell immunity to influenza. N. Engl.J. Med. 309: 13-17.
4. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal associations of cellular immune responses with the initial control of viremia in primary Human Immunodeficiency Virus type 1 syndrome. J. Virol. 68: 4650-4655.
5. Walker, B.D., S. Chakrabarti, B. Moss, T.J. Paradis, T. Flynn, A.G. Dumo, R.S. Blumberg, J.C. Kaplan, M.S. Hirsch, and R.T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (Lond.). 328: 345-348.
6. Hoffenbach, A., P. Langlade-Demoyen, G. Dadaglio, E. Vilmer, F. Michel, C. Mayaud, R. Autran, and F. Plata. 1989. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142: 452-462.
7. Clerici, M., D.R. Lucey, R.A. Zajac, R.N. Boswell, H.M. Gebel, H. Takahashi, J. A. Berzofsky, and G.M. Shearer, 1991. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gpl60 in HIV-seropositive individuals, f. Immunol. 146: 2214-2219.
8. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HlV-l)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp Med. 177: 249-256.
9. Zinkernagel, R.M., and H. Hengartner. 1994. T-cell mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol. Today. 15: 262-268.
10. Lamhamedi-Cherradi, S., B. Cullmann-Penciolelli, B. Guy, M.P. Kieny, F. Dreyfus, A.G. Saimot, D. Sereni, D. Sicard, J.P. Levy, and E. Gomard. 1992. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS (Phila.). 6: 1249-1258.
11. Buseyne, F., M. McChesney, F. Porrot, S. Kovarik, B. Guy, and Y. Riviere. 1993. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1 infected individuals: gae epitopes are clustered in three regions of the p24gag protein. J. Virol. 67: 694-702.
12. Nixon, D.F., A.R.M. Townsend, J.G. Elvin, C.R. Rizza, J. Gallwey, and A.J. McMichael. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature (Lond.). 336: 484-487.
13. Koup, R.A., C.A. Pikora, K. Luzuriaga, D.B. Brettler, E.S. Day, G.P. Mazzara, and J.L. Sullivan. 1991. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with pl7 and p24 specificities. J. Exp Med. 174: 1593-1600.
14. Johnson, R.P., A. Uocha, L. Yang, G.P. Mazzara, D.L. Panicali, T.M. Buchanan, and B.D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147: 1512-1521.
15. Van Baalen, C.A., M.R. Klein, A.M. Geretti, I.P.M. Keet, F. Miedema, C.A.C.M. Van Els, and A.D.M.E. Osterhaus. 1993. Selective in vitro expansion of HLA class I-restricted HIV-1 gag specific CD8+ T cells from seropositive individuals: Identification of CTL epitopes and precursor frequencies. AIDS (Phila.). 7: 781-786.
16. Venet, A., and B.D. Walker. 1993. Cytotoxic T-cell epitopes in HIV/SIV infection. AIDS (Phila.). 7: S117-S126.
17. De Wolf, F., J. Goudsmit, D.A. Paul, J.M.A. Lange, C. Hooijkaas, P.T.A. Schellekens, R.A. Coutinho, and J. Van der Noordaa. 1987. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br. Med. J. 295: 569-572.
18. van Griensven, G.J.P., E.M.M. de Vroome, J. Goudsmit, and R.A. Coutinho. 1989. Changes in sexual behavior and the fall in incidence of HIV infection among homosexual men. Br. Med. J. 298: 218-221.
19. Keet, I.P.M., P. Krijnen, M. Koot, J.M.A. Lange, F. Miedema, J. Goudsmit, and R.A. Coutinho. 1993. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS (Phila.). 7: 51-57.
20. Klein, M.R., I.P.M. Keet, J. D’Amaro, R.J. Bende, A. Hekman, B. Mesman, M. Koot, L.P. de Waal, R.A. Coutinho, and F. Miedema. 1994. Associations between HLA frequencies and pathogenic features of Human Immunodeficiency Virus Type 1 infection in seroconverters from the Amsterdam Cohort of homosexual men. J. Infect. Dis. 169: 1244-1249.
21. Centers for Disease Control. 1987. Revision of the CDC surveillance case definition of AIDS. Morh Mortal. Wkly. Rep 36: 3-15.
22. Keet, I.P.M., A. Krol, M.R. Klein, P. Veugelers, J. De Wit, M.T.L. Roos, M. Koot, J. Goudsmit, F. Miedema, and R.A. Coutinho. 1994. Characteristics of long-term asymptomatic infection with the Human Immunodeficiency Virus Type 1 with normal and low CD4+ cell counts. J. Infect. Dis. 169: 1236-1243.
23. Schellekens, P.T.A., M.T.L. Roos, F. De Wolf, J.M.A. Lange, and F. Miedema. 1990. Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for AIDS in HIV-1 infected men. J. Clin. Immunol. 10: 121-127.
24. Rautmann, G., M.P. Kieny, R. Brandely, K. Dott, M. Girard, L. Montagnier, and J.P. Lecocq. 1989. HIV-1 core proteins expressed from recombinant vaccinia viruses. AIDS Res. Hum. Retroviruses. 5: 147-157.
25. Meyers, G., A.B. Rabson, J.A. Berzofsky, T.F. Smith, and F. Wong-Staal. 1990. Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, NM.
26. Lefkovits, I., and H. Waldmann. 1979. Limiting Dilution Analysis of Cells in the Immune System. Cambridge University Press, Cambridge. 38-59.
27. Strijbosch, L.W.G., W.A. Buurman, R.J.M.M. Does, P.H. Zinken, and G. Groenewegen. 1987. Limiting dilution assays. Experimental design and statistical analysis. J. Immunol. Meth. 97: 133-140.
28. Schuitemaker, H., M. Root, N.A. Kootstra, M.W. Dercksen, R.E.Y. De Goede, R.P. Van Steenwijk, J.M. A. Lange, J.K.M. Eeftink Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66: 1354-1360.
29. Root, M., A.H.V. Vos, R.P.M. Reel, R.E.Y. De Goede, W. Dercksen, F.G. Terpstra, R.A. Coutinho, F. Miedema, and M. Tersmette. 1992. HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS (Phila.). 6: 49-54.
30. + cell depletion and progression to AIDS. Ann. Intern. Med. 118: 681-688.
31. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1 infected individuals. J. Virol. 67: 1772-1777.
32. Dadaglio, G., F. Michel, P. Langlade-Demoyen, P. Sansonetti, D. Chevrier, F. Vuillier, F. Plata, and A. Hoffenbach. 1992. Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment. Clin. Exp. Immunol. 87: 7-14.
33. Phillips, R.E., S. Rowland-Jones, D.F. Nixon, F.M. Gotch, J.P. Edwards, A.O. Ogunlesi, J.G. Elvin, J.A. Rothbard, C.R.M. Bangham, C.R. Rizza, and A.J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (Land.). 354: 453-459.
34. Meyerhans, A., G. Dadaglio, J.P. Vartanian, P. Langlade-Demoyen, R. Frank, B. Asjo, F. Plata, and S. Wain-Hobson. In vivo persistence of a HIV-1 encoded HLA-B27 restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur. J. Immunol. 21: 2637-2640.
35. Chen, Z.W., L. Shen, M.D. Miller, S.H. Ghim, A.L. Hughes, and N.L. Letvin. 1992. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J. Immunol. 149: 4060-4066.
36. Bacchetta, R., M. Bigler, J.-L. Touraine, R. Parkman, P.-A. Tovo, J. Abrams, R. de Waal Malefyt, J.E. de Vries, and M.-G. Roncarolo. 1994. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp Med. 179: 493-502.
37. Clerici, M., T.A. Wynn, J.A. Berzofsky, S.P. Blatt, C.W. Hendrix, A. Sher, R.L. Coffman, and G.M. Shearer. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93: 768-775.
38. Moskophidis, D., F. Lechner, H. Pircher, and R.M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (Lond.). 362: 758-761.
39. − T cell population. J. Immunol. 144: 1696-1704.
40. Learmont, J., B. Tindall, L.A. Evans, A. Cunningham, P. Cunningham, J. Wells, R. Penny, J. Ralsor, and D.A. Cooper. 1992. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet. 340: 863-867.
41. Greenough, T.C., M. Somasundaran, D.B. Brettler, R.M. Hesselton, A. Alimenti, F. Rirchhoff, D. Panicali, and J.L. Sullivan. 1994. Normal immune function and inability to isolate virus in culture in an individual with long-term Human Immunodeficiency Virus Type-1 infection. AIDS Res. Hum. Retroviruses. 10: 395-403.
42. Pedersen, C., B.O. Lindhardt, B.L. Jensen, E. Lauritzen, J. Gerstoft, E. Dickmeiss, J. Gaub, E. Scheibel, and T. Rarlsmark. 1989. Clinical course of primary HIV infection: Consequences for subsequent course of infection. Br. Med. J. 298: 154-157.